Myasthenic crisis in COVID-19

• Myasthenic crises is a potentially severe complication of COVID-19. • Hydroxychloroquine can aggravate myasthenia crises. • IVIg is a potential treatment for both Myasthenic crises and COVID-19. • IVIg treatment may cause thrombosis in susceptible patients.

Detalles Bibliográficos
Autores principales: Delly, Fadi, Syed, Maryam J., Lisak, Robert P., Zutshi, Deepti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200364/
https://www.ncbi.nlm.nih.gov/pubmed/32413767
http://dx.doi.org/10.1016/j.jns.2020.116888
Descripción
Sumario:• Myasthenic crises is a potentially severe complication of COVID-19. • Hydroxychloroquine can aggravate myasthenia crises. • IVIg is a potential treatment for both Myasthenic crises and COVID-19. • IVIg treatment may cause thrombosis in susceptible patients.

Ejemplares similares